New round of capital injections for pet players worldwide

Pet firms across the world ended 2025 with fresh capital to support expansions and technological advancements. GlobalPETS examines the latest developments.

KatKin

KatKin, a British fresh cat food brand, secured $50 million (€46M) in a Series C equity and debt funding.

The capital injection will support the company’s expansion across the UK to scale its direct-to-consumer (DTC) and pet specialty retail channels.

“It will also accelerate our product innovation roadmap, including new textures and formulations designed to serve more cats and strengthen our vertically integrated model, from in-house production to scientific research,” the company says.

Founded in 2019, KatKin produces fresh-cooked cat food claiming to use no fillers, grains or preservatives. According to the manufacturer, its proprietary algorithm helps customers build personalized boxes of meals, although it also partners with British pet retailers like Jollyes. 

Hello Vet

London-based veterinary firm Hello Vet closed its Series A funding with £15 million ($19M/€17M) on 11 December, bringing its total investment to £21 million ($27M/€24M). The round was led by venture capital firms Addition and Future Positive, with participation from 15 specialist vets. 

The company will use this funding to support its UK expansion, which involves launching clinics across the country and hiring a team of 200 vets and vet nurses over the next two years. Founded in 2022, Hello Vet now has 7,500 registered patients.

“We’re aiming to open 20-30 clinics, but the exact pace will be determined by our ability to grow sustainably. We’re committed to expanding in a way that never compromises the quality of care or the well-being of our teams. Ultimately, we’d rather do it in four years well than in one and a half years badly,” James Lighton, Co-founder and CEO of Hello Vet, tells GlobalPETS.

In addition, the company will invest in proprietary technology and AI to optimize operations. “We will continue to invest heavily in our in-house technology and selected third-party tools. Our goal is to reduce administrative time, streamline workflows and ensure our clinical teams can focus on delivering the best possible care to pets and their owners,” Lighton says.

Dr. Paws

Indian veterinary clinic chain Dr. Paws secured ₹29.3 crore ($3.5M/€3.3M) in its Pre-Series A round led by Chiratae Ventures, with participation from Sauce Venture Capitals, angel investors and venture debt from Trifecta Capital and Stride Ventures.

With the new capital, the veterinary firm will add 9 new clinics from Bengaluru, in southern India, and expand operations to Hyderabad and Pune, approximately 700km and 150km from Mumbai, respectively. It will also launch at-home veterinary services along with its own-label products across functional treats, supplements and food.

The Bengaluru-based company currently operates three 24/7 clinics in the city, has served over 30,000 appointments, and completed more than 800 surgeries. It currently has 2 clinics under construction.

Right4Paws

Indian pet nutrition brand Right4Paws raised ₹14 crore ($1.7M/€1.6M) from its Series A funding round, which closed on 17 December. 

The company, owned by Pet Prakalp India, will use the new capital to expand its manufacturing infrastructure, scale production capacity, and strengthen internal capabilities. They also want to boost manpower, expand product offerings across functional and life-stage nutrition, and grow their distribution footprint across Indian markets.

“This Series A funding gives us the foundation to expand rapidly, enter new product categories and prepare for international markets, while staying true to our focus on transparency, research-driven innovation and real health outcomes for pets,” says Sameer Achan, Co-founder and Director of Right4Paws.